Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. The multi-year agreement will allow BMS to scale AI-powered workflows across trial design, ...

I’m already loving this device, and I haven’t even touched one. Arduino announced it has collaborated with M5Stack to develop the new compact and powerful Nesso N1 IoT development kit. This system ...

When [OGS Mechanics] got a Mercedes EQC 300 battery-electric car in for repair, it was found to have a bit of a weird issue: ...

MicroPython is a well-known and easy-to-use way to program microcontrollers in Python. If you’re using an Arduino Uno Q, though, you’re stuck without it. [Natasha] saves the day by bringing us a a ...

The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the end of an era. Medarex is one of the last independent public biotech companies that built their businesses around ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...